Jose M. Diaz-Sanchez

Sevilla, AN 41013, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Biomarkers of Venous Thromboembolism Recurrence after Discontinuation of Low Molecular Weight Heparin Treatment for Cancer-Associated Thrombosis (HISPALIS-Study).

Biomarkers of Venous Thromboembolism Recurrence after Discontinuation of Low Molecular Weight Heparin Treatment for Cancer-Associated Thrombosis (HISPALIS-Study).

Journal: Cancers
Published: May 10, 2022

Case-Control Analysis of the Impact of Anemia on Quality of Life in Patients with Cancer: A Qca Study Analysis.

Case-Control Analysis of the Impact of Anemia on Quality of Life in Patients with Cancer: A Qca Study Analysis.

Journal: Cancers
Published: March 29, 2021

Analysis of the Indications and Complications of Vena Cava Filter in Patients with Venous Thromboembolism.

Analysis of the Indications and Complications of Vena Cava Filter in Patients with Venous Thromboembolism.

Journal: Archivos de bronconeumologia
Published: November 11, 2020

Prognostic Significance of Incidental Deep Vein Thrombosis in Patients with Cancer Presenting with Incidental Pulmonary Embolism.

Prognostic Significance of Incidental Deep Vein Thrombosis in Patients with Cancer Presenting with Incidental Pulmonary Embolism.

Journal: Cancers
Published: June 29, 2020

Risk Of Recurrence After Withdrawal Of Anticoagulation In Patients With Unprovoked Venous Thromboembolism: External Validation Of The Vienna Nomogram And The Dash Prediction Score.

Risk Of Recurrence After Withdrawal Of Anticoagulation In Patients With Unprovoked Venous Thromboembolism: External Validation Of The Vienna Nomogram And The Dash Prediction Score.

Journal: Archivos de bronconeumologia
Published: February 06, 2019

D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis.

D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis.

Journal: British journal of cancer
Published: April 26, 2018

Tinzaparin in cancer associated thrombosis beyond 6months: TiCAT study.

Tinzaparin in cancer associated thrombosis beyond 6months: TiCAT study.

Journal: Thrombosis research
Published: February 12, 2017

Clinically relevant bleeding and thrombotic events in non-cirrhotic splanchnic vein thrombosis. Long-term follow up.

Clinically relevant bleeding and thrombotic events in non-cirrhotic splanchnic vein thrombosis. Long-term follow up.

Journal: Thrombosis research
Published: December 23, 2016
Showing 1-8 of 8

Last Updated: 09/26/2026